SWOT Analysis for Ajooni Biotech Ltd.

Price crossing above SMA20 today, and greater than SMA5
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers

Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Declining Net Cash Flow : Companies not able to generate net cash
Stocks Underperforming their Industry Price Change in the Quarter

Bullish or Bearish Candlestick Strength - Indices
Bullish Harami (Bullish Reversal)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Ajooni Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats